PEDIATRIC CRITICAL CARE DEPARTMENT OF UNIVERSITY OF UTAH

100 N MARIO CAPECCHI DR

Articles

Biosimilar Growth Impressive But New Policies Needed, AAM Exec Says

October 08, 2021

Three pieces of legislation that would provide incentives to prescribers and put generics and biosimilars in favorable formulary tiers would speed further prescribing and use of biosimilars, Christine Simmon told Managed Healthcare Executive.®